Read more »
Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability
SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced top–line results of the SYCAMORE trial, a [...] Read more »
A Deriv celebra o seu 25.º aniversário com a distinção “UK’s Best Workplaces in Financial Services & Insurance™”
- O escritório no Reino Unido também renovou as suas certificações Great Place to Work® juntamente com outros seis [...] Read more »
Deriv Celebrates 25th Anniversary with “UK’s Best Workplaces in Financial Services & Insurance™” Win
- UK office has also received a renewal for its Great Place to Work® certifications alongside six other Deriv offices
- Read more »
Deriv célèbre son 25e anniversaire avec la récompense “UK’s Best Workplaces in Financial Services & Insurance™”
- Deriv a également renouvelé les certifications Great Place to Work de ses bureaux basés au Royaume–Uni et dans six autres [...] Read more »
Pandemic’s Silver Lining—Africa Uses COVID-19 Technology for Agriculture
By Jewel Fraser
Read more »
Israel’s Goal: Smashing Palestinian Legitimacy
World Leaders Who Opted to Skip the United Nations